Critique internationale
Presses de Sc. Po.

I.S.B.N.2724630297
222 pages

p. 87 à 106
doi: en cours

Veille sur la revue
Veille sur l'auteur
Vous consultez

no 29 2005/4

Concurrence réglementaire contre santé publique ?

Le contrôle des médicaments dans l’Union européenne

Boris Hauray
The emergence of a European political space in the pharmaceutical sector has created competition between regulatory agencies. But regulatory competition has long been recognized as a potential downward pressure on regulation standards. As a consequence, this article discusses the hypothesis of a “race to the bottom” in the sanitary control of medicines in Europe. After describing the growing rivalry between sanitary authorities in Europe since the 1960s, the author identifies several threats it represents for public health care. He nevertheless states that regulatory competition has not led to a weakening of public controls. In fact, the economic aspect of regulatory competition should not be overestimated: the European medicines regulatory system implies confrontation between experts that reinforces public supervision and, in this field, cooperation and normalization have always framed the dynamics of competition.
• Le contrôle sanitaire des médicaments et la formation d’un espace concurrentiel européen
— Les étapes de l’accroissement de l’interdépendance et de la concurrence européenne
— Concurrences territoriale et institutionnelle
• Un marché des autorités de régulation
— La diversification des stratégies d’influence des entreprises
— Des logiques clientélistes
• Espace européen et santé publique
— Concurrence européenne et renforcement des capacités de contrôle
— La confrontation des expertises
— La coopération européenne


© Cairn 2007 Vie privée | Conditions d’utilisation | Conditions générales de vente
À propos | Éditeurs | Bibliothèques | Aide à la navigation | Plan du site | Raccourcis